Citadel Advisors »

Ani Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $27M 20M 1.41

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Ani Pharmaceuticals

Linden Advisors
Camden Asset Management
BlackRock
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
Jpmorgan Chase & Co
Lazard Asset Management
Polar Securities
Gabelli Funds
Leucadia National Corporation
Universal- Beteiligungs- und Servicegesellschaft mbH
Picton Mahoney Asset Management
FMR

View all funds holding Ani Pharmaceuticals